Cargando…

Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization

BACKGROUND: Interactions between the gut microbiota, microglia, and aging may modulate Alzheimer’s disease (AD) pathogenesis but the precise nature of such interactions is not known. METHODS: We developed an integrated multi-dimensional, knowledge-driven, systems approach to identify interactions am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, QuanQiu, Davis, Pamela B., Qi, Xin, Chen, Shu G., Gurney, Mark E., Perry, George, Doraiswamy, P. Murali, Xu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529734/ https://www.ncbi.nlm.nih.gov/pubmed/34670619 http://dx.doi.org/10.1186/s13195-021-00917-1

Ejemplares similares

Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
por: Xu, Rong, et al.
Publicado: (2016)

Automatic extraction, prioritization and analysis of gut microbial metabolites from biomedical literature
por: Wang, QuanQiu, et al.
Publicado: (2020)

Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
por: Wang, QuanQiu, et al.
Publicado: (2019)

COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States
por: Wang, QuanQiu, et al.
Publicado: (2020)

Reply to “Post‐COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia”
por: Davis, Pamela B., et al.
Publicado: (2022)

A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer
por: Wang, QuanQiu, et al.
Publicado: (2018)

Comparing a knowledge-driven approach to a supervised machine learning approach in large-scale extraction of drug-side effect relationships from free-text biomedical literature
por: Xu, Rong, et al.
Publicado: (2015)

dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text
por: Xu, Rong, et al.
Publicado: (2014)

A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat
por: Xu, Rong, et al.
Publicado: (2015)

Probing gut‐brain links in Alzheimer's disease with rifaximin
por: Suhocki, Paul V., et al.
Publicado: (2022)

Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
por: Wang, Lindsey, et al.
Publicado: (2021)

Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
por: Xu, Rong, et al.
Publicado: (2013)

Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
por: Xu, Rong, et al.
Publicado: (2014)

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
por: Xu, Rong, et al.
Publicado: (2016)

Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis
por: Wang, QuanQiu, et al.
Publicado: (2018)

Gut Microbiota to Microglia: Microbiome Influences Neurodevelopment in the CNS
por: Bettag, Jeffery, et al.
Publicado: (2023)

Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action
por: Shin, Jaewook, et al.
Publicado: (2016)

“Sentinel or accomplice”: gut microbiota and microglia crosstalk in disorders of gut–brain interaction
por: Zheng, Haonan, et al.
Publicado: (2023)

When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer’s Disease
por: Lin, Katherine Amy, et al.
Publicado: (2015)

Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
por: Wang, QuanQiu, et al.
Publicado: (2020)

When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities
por: Wang, QuanQiu, et al.
Publicado: (2021)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Antibiotics, gut microbiota, and Alzheimer’s disease
por: Angelucci, Francesco, et al.
Publicado: (2019)

Gut Microbiota: Implications in Alzheimer’s Disease
por: He, Yixi, et al.
Publicado: (2020)

Nutrition, Gut Microbiota, and Alzheimer's Disease
por: Romanenko, Mariana, et al.
Publicado: (2021)

Gut Microbiota and Immunotherapy for Alzheimer’s Disease
por: Dai, Chun-Ling, et al.
Publicado: (2022)

Mobile and pervasive computing technologies and the future of Alzheimer’s clinical trials
por: Doraiswamy, P. Murali, et al.
Publicado: (2018)

Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia
por: Dodiya, Hemraj B., et al.
Publicado: (2021)

Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease
por: Petrella, Jeffrey R., et al.
Publicado: (2019)

Microglia in Alzheimer's Disease
por: Li, Ying, et al.
Publicado: (2014)

Microglia in Alzheimer's Disease
por: Jin, Lee-Way
Publicado: (2012)

Microglia in Alzheimer’s disease
por: Hansen, David V., et al.
Publicado: (2018)

Microglia and Alzheimer’s Disease
por: Merighi, Stefania, et al.
Publicado: (2022)

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Kowalski, Karol, et al.
Publicado: (2019)

d-glutamate and Gut Microbiota in Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2020)

Gut microbiota and pro/prebiotics in Alzheimer’s disease
por: Pluta, Ryszard, et al.
Publicado: (2020)

Effects of gut microbiota and probiotics on Alzheimer’s disease
por: Guo, Libing, et al.
Publicado: (2021)

IMPACT OF CALORIE RESTRICTION ON PLASMA ALZHEIMER’S DISEASE BIOMARKERS IN HEALTHY YOUNG AND MIDDLE-AGED ADULTS
por: Parker, Daniel, et al.
Publicado: (2022)

Multiomics Revealed the Multi-Dimensional Effects of Late Sleep on Gut Microbiota and Metabolites in Children in Northwest China
por: Xiang, Xuesong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ta1qg5hgpeel4230sqvd9sh6t7